Resources

Removing Risk Evaluation and Mitigation Strategy (REMS) Categorization on Mifepristone

A 2018 policy resolution calling for the AAFP to engage in efforts to overturn the Risk Evaluation and Mitigation Strategy (REMS) classification on Mifepristone. The resolution was adopted by the 2018 Congress of Delegates.

 

Insights into Abortion and Miscarriage Care

This bi-monthly clinical e-newsletter highlights evidenced-based best practices in abortion and miscarriage care

Latest Blog Post

View More Posts on Topic